NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Lila Sciences

Lila Sciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.lila.ai/

Last Round

Series B

Jun 3, 2026

Est. Valuation

$10.5B

Total Funding Raised

$785M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Lila Sciences is a biotechnology company that develops a scientific superintelligence platform combining generative AI with autonomous lab systems to automate and accelerate scientific experimentation and discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Revenue Share

AI Layer

Application

Keywords

autonomous labslab-as-a-servicescientific superintelligencedrug discoveryAI research platformautomated experimentationbiotech AIAI-native scienceR&D automationventure creationusage-based SaaScloud labAI agentfrontier AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lila Sciences Comparables

Compare Lila Sciences with similar companies based on industry and business-model similarity.

Lila Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Recursion Pharmaceuticals
78%
Ginkgo Bioworks
76%
Alphabet Inc.
73%

Lila Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 3, 2026
Series AOct 10, 2025
Series ASep 15, 2025
SeedMar 10, 2025

Secondary Market Activity

Bids, offers, and trades by month

Data table
OperationDatePriceSizeShare ClassStructure
BID
OFFER

Key People

Founding team and executive leadership

Rafael Gómez Bombarelli

Chief Scientific Officer, Physical Sciences Co-founder

Founding Team

Scott Robertson

Co-Founder Chief Commercial Officer

Founding Team

Geoffrey von Maltzahn

Co-Founder, Chief Executive Officer

Founding Team

Andrew Beam

Chief Technology Officer

Executive Team

Lila Sciences Investors

Notable investors and investment history

Lila Sciences investors
InvestorRounds
Pennant InvestorsSeries A
California Public Employees' Retirement SystemSeries B
Altitude Life Science VenturesSeed, Series A
BraidwellSeries A
Dara HoldingsSeries A
Dauntless VenturesSeries A
NVenturesSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    $2.0B round led by NVentures and CalPERS.

  • May 17, 2026

    Monthly visitors increased 30% MoM, reaching 65.8K.

Lila Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lila Sciences Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Lila Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range445
Year Founded2023
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.